Tiny stem cell companies close in on goals – The Australian
Jakarta Globe |
Tiny stem cell companies close in on goals
The Australian Athersys's experimental Multistem treatment was one of the first companies to be designated by the US Food and Drug Administration as a promising cell-based therapy with potential to address unmet needs for serious or life-threatening conditions … Tiny Stem Cell Companies Close in on Major Heart Disease Goals |
